In silico analyses of heat shock protein 60 and calreticulin to designing a novel vaccine shifting immune response toward T helper 2 in atherosclerosis

Recent experiments demonstrated that atherosclerosis is a Th1 dominant autoimmune condition, whereas Th2 cells are rarely detected within the atherosclerotic lesions. Several studies have indicated that Th2 type cytokines could be effective in the reduction and stabilization of atherosclerotic plaque. Therefore, the modulation of the adaptive immune response by shifting immune responses toward Th2 cells by a novel vaccine could represent a promising approach to prevent from progression and thromboembolic events in coronary artery disease. In the present study, an in silico approach was applied to design a novel multi-epitope vaccine to elicit a desirable immune response against atherosclerosis. Six novel IL-4 inducing epitopes were selected from HSP60 and calreticulin proteins. To enhance epitope presentation, IL-4 inducing epitopes were linked together by AAY and HEYGAEALERAG linkers. In addition, helper epitopes selected from Tetanus toxin fragment C (TTFrC) were applied to induce CD4+ helper T lymphocytes (HTLs) responses. Moreover, cholera toxin B (CTB) was employed as an adjuvant. A multi-epitope construct was designed based on predicted epitopes which was 320 residues in length. Then, the physico-chemical properties, secondary and tertiary structures, stability, intrinsic protein disorder, solubility and allergenicity of this chimeric protein were analyzed using bioinformatics tools and servers. Based on bioinformatics analysis, a soluble, and non-allergic protein with 35.405kDa molecular weight was designed. Expasy ProtParam classified this chimeric protein as a stable protein. In addition, predicted epitopes in the chimeric vaccine indicated strong potential to induce B-cell mediated immune response and shift immune responses toward protective Th2 immune response. Various in silico analyses indicate that this vaccine is a qualified candidate for improvement of atherosclerosis by inducing immune responses toward T helper 2.

[1]  Wei Li,et al.  Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines , 2007, BMC Bioinformatics.

[2]  Chaok Seok,et al.  Refinement of unreliable local regions in template‐based protein models , 2012, Proteins.

[3]  P. Shah,et al.  CD8+ T Cells Mediate the Athero-Protective Effect of Immunization with an ApoB-100 Peptide , 2012, PloS one.

[4]  Pierre Baldi,et al.  SOLpro: accurate sequence-based prediction of protein solubility , 2009, Bioinform..

[5]  G. Hansson.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[6]  R D Appel,et al.  Protein identification and analysis tools in the ExPASy server. , 1999, Methods in molecular biology.

[7]  H. Dyson,et al.  Intrinsically disordered proteins in cellular signalling and regulation , 2014, Nature Reviews Molecular Cell Biology.

[8]  Sandeep Kumar Dhanda,et al.  Prediction of IL4 Inducing Peptides , 2013, Clinical & developmental immunology.

[9]  Subhash C. Basak,et al.  A Brief Review of Computer-Assisted Approaches to Rational Design of Peptide Vaccines , 2016, International journal of molecular sciences.

[10]  Manfred J. Sippl,et al.  Thirty years of environmental health research--and growing. , 1996, Nucleic Acids Res..

[11]  E. Magen,et al.  Chronic Opisthorchis felineus infection attenuates atherosclerosis--an autopsy study. , 2013, International journal for parasitology.

[12]  Ian W. Davis,et al.  Structure validation by Cα geometry: ϕ,ψ and Cβ deviation , 2003, Proteins.

[13]  Dieter Jahn,et al.  JCat: a novel tool to adapt codon usage of a target gene to its potential expression host , 2005, Nucleic Acids Res..

[14]  Sudipto Saha,et al.  Prediction of continuous B‐cell epitopes in an antigen using recurrent neural network , 2006, Proteins.

[15]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[16]  C. Grundtman,et al.  The role of heat shock proteins in atherosclerosis , 2014, Nature Reviews Cardiology.

[17]  Gajendra P. S. Raghava,et al.  AlgPred: prediction of allergenic proteins and mapping of IgE epitopes , 2006, Nucleic Acids Res..

[18]  Andrzej Kloczkowski,et al.  GOR V server for protein secondary structure prediction , 2005, Bioinform..

[19]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[20]  Ahmad Karkhah,et al.  A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approach , 2016, Clinical and experimental vaccine research.

[21]  Morten Nielsen,et al.  Reliable B Cell Epitope Predictions: Impacts of Method Development and Improved Benchmarking , 2012, PLoS Comput. Biol..

[22]  P. Shah,et al.  Can We Vaccinate Against Atherosclerosis? , 2014, Journal of cardiovascular pharmacology and therapeutics.

[23]  J. Kuiper,et al.  Vaccination strategies in atherosclerosis , 2011, Thrombosis and Haemostasis.

[24]  H. Dyson,et al.  Intrinsically unstructured proteins and their functions , 2005, Nature Reviews Molecular Cell Biology.

[25]  V. Kakkar,et al.  The role of T-helper cells in atherosclerosis. , 2011, Cardiovascular & hematological agents in medicinal chemistry.

[26]  Antonio Lanzavecchia,et al.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells , 1989, European journal of immunology.

[27]  M. Sternberg,et al.  Protein structure prediction on the Web: a case study using the Phyre server , 2009, Nature Protocols.

[28]  Irun R Cohen,et al.  Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxis. , 2006, International immunology.

[29]  Ali Azizi,et al.  Innovative bioinformatic approaches for developing peptide‐based vaccines against hypervariable viruses , 2011, Immunology and cell biology.

[30]  François Mach,et al.  Immunization of LDL receptor-deficient mice with β2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques , 2006, Thrombosis and Haemostasis.

[31]  Liam J. McGuffin,et al.  The PSIPRED protein structure prediction server , 2000, Bioinform..

[32]  Morten Nielsen,et al.  Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification , 2015, Immunogenetics.

[33]  Gadi Borkow,et al.  Can worms defend our hearts? Chronic helminthic infections may attenuate the development of cardiovascular diseases. , 2005, Medical hypotheses.

[34]  John Andersson,et al.  Adaptive immunity and atherosclerosis. , 2010, Clinical immunology.

[35]  David T. Jones,et al.  DISOPRED3: precise disordered region predictions with annotated protein-binding activity , 2014, Bioinform..

[36]  R. Jacob,et al.  Inflammation and the development of atherosclerosis. , 2011, Journal of atherosclerosis and thrombosis.

[37]  T. Stratmann,et al.  Cholera Toxin Subunit B as Adjuvant––An Accelerator in Protective Immunity and a Break in Autoimmunity , 2015, Vaccines.

[38]  A. Tedgui,et al.  The role of adaptive T cell immunity in atherosclerosis Ziad Mallat is a recipient of a Contrat d'Interface from Assistance Publique-Hôpitaux de Paris. Published, JLR Papers in Press, December 2, 2008. , 2009, Journal of Lipid Research.

[39]  Jacob George,et al.  Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. , 2002, Journal of the American College of Cardiology.

[40]  Christian Klotz,et al.  Calreticulin from the intestinal nematode Heligmosomoides polygyrus is a Th2-skewing protein and interacts with murine scavenger receptor-A. , 2009, Molecular immunology.

[41]  G. Ferns,et al.  Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. , 2003, Atherosclerosis.

[42]  Ellis L. Reinherz,et al.  Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles , 2004, Immunogenetics.